Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence

Assistance Publique Hopitaux De Marseille1 site in 1 country14 target enrollmentMay 2008

ConditionsCervical Intraepithelial Neoplasia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cervical Intraepithelial Neoplasia
Sponsor: Assistance Publique Hopitaux De Marseille
Enrollment: 14
Locations: 1
Primary Endpoint: The detection and the quantification of the DNA of the human oncogènes papillomavirus of type 16 and 18
Status: Terminated
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Relationship between HPV infection and cervical cancer is well established. Among the HPV types identified to date, 15 are classified as high risk HPV (HR-HPV). Detection of HR-HPV has been proposed to optimize cervical cancer screening.

Detailed Description

A prospective detection and quantification of HR-HPV in patients with proven CIN1 will be performed. Relationship between HR-HPV initial viral load and the CIN1 persistence will be evaluated.

Registry

clinicaltrials.gov

Start Date

May 2008

End Date

February 2013

Last Updated

11 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Female

Investigators

Sponsor

Assistance Publique Hopitaux De Marseille

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•The women whose last one FCV of screening put in evidence a LIEBG of the neck of the womb having been confirmed by the colposcopie.
•The inclusive patients will be of more than 18 years old. All the patients will be profitable of a regime of Social Security.

Exclusion Criteria

•The patients whose result of the colposcopie is clashing with that of the FCV of initial screening (normal collar, LIEHG or the other one).
•The patients having an antecedent of DREGS of the neck of the womb, that this one was or not handled
•The patients having had a hysterectomy.
•The patients incapable to receive the information enlightened on the progress and the objectives of the study
•The patients not having signed enlightened assent